-
1
-
-
0004496862
-
Adjuvant tamoxifen in the managemsent of operable breast cancer: The Scottish trial
-
Bartlett K, Ermin O, Hutcheon A, Preece P, Scott J S, Forrest P, Chetty U, Prescott R J, Rodger A, Smyth J, George D, Habeshaw T, Kaye S B, McArdle C S, McCallum M, Smith D C, McMillan B, Robinson S M, Stewart H J, White G K, Giles G R. Adjuvant tamoxifen in the management of operable breast cancer: the Scottish trial. Lancet. 2:1987;171-175.
-
(1987)
Lancet
, vol.2
, pp. 171-175
-
-
Bartlett, K.1
Ermin, O.2
Hutcheon, A.3
Preece, P.4
Scott, J.S.5
Forrest, P.6
Chetty, U.7
Prescott, R.J.8
Rodger, A.9
Smyth, J.10
George, D.11
Habeshaw, T.12
Kaye, S.B.13
McArdle, C.S.14
McCallum, M.15
Smith, D.C.16
McMillan, B.17
Robinson, S.M.18
Stewart, H.J.19
White, G.K.20
Giles, G.R.21
more..
-
2
-
-
0024506261
-
A randomized, clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors
-
Fisher B, Costantino J, Redmond L, Poisson R, Bowman D, Couture J, Dimitrov N V, Wolmark N, Wickerham D L, Fisher E R, Margolese R, Robioux A, Shibata H, Terz J, Paterson A HG, Feldman M I, Farrer W, Evans J, Lickley H L, Ketner M. A randomized, clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors. N Engl J Med. 320:1989;479-484.
-
(1989)
N Engl J Med
, vol.320
, pp. 479-484
-
-
Fisher, B.1
Costantino, J.2
Redmond, L.3
Poisson, R.4
Bowman, D.5
Couture, J.6
Dimitrov, N.V.7
Wolmark, N.8
Wickerham, D.L.9
Fisher, E.R.10
Margolese, R.11
Robioux, A.12
Shibata, H.13
Terz, J.14
Paterson, A.H.G.15
Feldman, M.I.16
Farrer, W.17
Evans, J.18
Lickley, H.L.19
Ketner, M.20
more..
-
3
-
-
0023888245
-
Controlled trial of tamoxifen as a single adjuvant agent in management of early breast cancer
-
Baum M, Brinkley D M, Dosset J A. Controlled trial of tamoxifen as a single adjuvant agent in management of early breast cancer. Br J Cancer. 57:1988;609-611.
-
(1988)
Br J Cancer
, vol.57
, pp. 609-611
-
-
Baum, M.1
Brinkley, D.M.2
Dosset, J.A.3
-
4
-
-
0021333005
-
Endocrine effects of tamoxifen in postmenopausal breast cancer patients
-
Boccardo F, Guarnieri D, Rubagotti A, Casertelli G L, Bentivoglio G, Conte N, Campanella G, Gaggaro G, Comalli G, Zanardi S, Nicolo G. Endocrine effects of tamoxifen in postmenopausal breast cancer patients. Tumori. 70:1984;61-68.
-
(1984)
Tumori
, vol.70
, pp. 61-68
-
-
Boccardo, F.1
Guarnieri, D.2
Rubagotti, A.3
Casertelli, G.L.4
Bentivoglio, G.5
Conte, N.6
Campanella, G.7
Gaggaro, G.8
Comalli, G.9
Zanardi, S.10
Nicolo, G.11
-
5
-
-
0027172047
-
A current view of tamoxifen for treatment and prevention of breast cancer
-
Jordan V C. A current view of tamoxifen for treatment and prevention of breast cancer. Br J Pharmacol. 110:1993;507-517.
-
(1993)
Br J Pharmacol
, vol.110
, pp. 507-517
-
-
Jordan, V.C.1
-
6
-
-
0027263114
-
Endometrial changes in postmenopausal women treated with tamoxifen for breast cancer
-
Cohen I, Rosen D JD, Shapira J, Cordoba M, Gilboa S, Altaras M M, Yigael D, Beyth Y. Endometrial changes in postmenopausal women treated with tamoxifen for breast cancer. Br J Obstet Gynaecol. 100:1993;567-570.
-
(1993)
Br J Obstet Gynaecol
, vol.100
, pp. 567-570
-
-
Cohen, I.1
Rosen, D.J.D.2
Shapira, J.3
Cordoba, M.4
Gilboa, S.5
Altaras, M.M.6
Yigael, D.7
Beyth, Y.8
-
7
-
-
0027299818
-
Endometrial changes in postmenopausal breast cancer patients receiving tamoxifen
-
Lahti E, Blanco G, Kauppila A, Apaja-Sarkkinen M, Taskinen P J, Laatikainen T. Endometrial changes in postmenopausal breast cancer patients receiving tamoxifen. Obstet Gynecol. 81:1993;660-664.
-
(1993)
Obstet Gynecol
, vol.81
, pp. 660-664
-
-
Lahti, E.1
Blanco, G.2
Kauppila, A.3
Apaja-Sarkkinen, M.4
Taskinen, P.J.5
Laatikainen, T.6
-
8
-
-
0023719255
-
Tamoxifen as risk factor for carcinoma of corpus uteri (letter)
-
Hardell L. Tamoxifen as risk factor for carcinoma of corpus uteri (letter). Lancet. 3:1988;563.
-
(1988)
Lancet
, vol.3
, pp. 563
-
-
Hardell, L.1
-
9
-
-
0026741596
-
Carcinogenic effects of adjuvant tamoxifen treatment and radiotherapy for early breast cancer
-
Andersson M, Storm H H, Mouridsen H T. Carcinogenic effects of adjuvant tamoxifen treatment and radiotherapy for early breast cancer. J Natl Cancer Inst. 31:1992;259-263.
-
(1992)
J Natl Cancer Inst
, vol.31
, pp. 259-263
-
-
Andersson, M.1
Storm, H.H.2
Mouridsen, H.T.3
-
10
-
-
0025856077
-
Tamoxifen in premenopausal patients with metastatic breast cancer: A review
-
Sunderland M C, Osborne C K. Tamoxifen in premenopausal patients with metastatic breast cancer: a review. J Clin Oncol. 9:1991;1283-1297.
-
(1991)
J Clin Oncol
, vol.9
, pp. 1283-1297
-
-
Sunderland, M.C.1
Osborne, C.K.2
-
11
-
-
0028208456
-
Endometrial cancer in tamoxifen-treated breast cancer patients: Findings from the national surgical adjuvant breast and bowel project (NSABP) B-14
-
Fisher B, Costantino J P, Redmond C K, Fisher E R, Wickerham D L, Cronin W M. Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the national surgical adjuvant breast and bowel project (NSABP) B-14. J Natl Cancer Inst. 86:1994;527-537.
-
(1994)
J Natl Cancer Inst
, vol.86
, pp. 527-537
-
-
Fisher, B.1
Costantino, J.P.2
Redmond, C.K.3
Fisher, E.R.4
Wickerham, D.L.5
Cronin, W.M.6
-
12
-
-
0028053224
-
Risk of endometrial cancer after tamoxifen treatment of breast cancer
-
Leeuwen F E, Benraadt J, Coebergh J WW, Kiemeney L A, Gimbrere C H, Otter R, Schouten L J, Damhuis R A, Bontenbal M, Diepenhorst F W, van den Belt-Dusebout A W, van Tinteren H. Risk of endometrial cancer after tamoxifen treatment of breast cancer. Lancet. 343:1994;448-452.
-
(1994)
Lancet
, vol.343
, pp. 448-452
-
-
Leeuwen, F.E.1
Benraadt, J.2
Coebergh, J.W.W.3
Kiemeney, L.A.4
Gimbrere, C.H.5
Otter, R.6
Schouten, L.J.7
Damhuis, R.A.8
Bontenbal, M.9
Diepenhorst, F.W.10
Van Den Belt-Dusebout, A.W.11
Van Tinteren, H.12
-
13
-
-
0024546736
-
Adjuvant tamoxifen in early breast cancer: Occurrence of new primary cancers
-
Fornander T, Rutquist L E, Cedarmark B, Mattsson A, Skoog L, Theve T. Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers. Lancet. 1:1989;117-120.
-
(1989)
Lancet
, vol.1
, pp. 117-120
-
-
Fornander, T.1
Rutquist, L.E.2
Cedarmark, B.3
Mattsson, A.4
Skoog, L.5
Theve, T.6
-
15
-
-
0025816156
-
Endometrial morphology in asymptomatic postmenopausal women
-
Archer D F, McIntyre-Seltman K, Wilborn W W, Dowling E A, Cone F, Creasy G W, Kafrissen M E. Endometrial morphology in asymptomatic postmenopausal women. Am J Obstet Gynecol. 165:1991;317-322.
-
(1991)
Am J Obstet Gynecol
, vol.165
, pp. 317-322
-
-
Archer, D.F.1
McIntyre-Seltman, K.2
Wilborn, W.W.3
Dowling, E.A.4
Cone, F.5
Creasy, G.W.6
Kafrissen, M.E.7
-
16
-
-
0028158119
-
Endometrial change with tamoxifen: Comparison between tamoxifen-treated and nontreated asymptomatic, postmenopausal breast cancer patients
-
Cohen I, Rosen D JD, Shapira J, Cordoba M, Gilboa S, Altaras M M, Yigael D. Endometrial change with tamoxifen: comparison between tamoxifen-treated and nontreated asymptomatic, postmenopausal breast cancer patients. Gynecol Oncol. 52:1994;185-190.
-
(1994)
Gynecol Oncol
, vol.52
, pp. 185-190
-
-
Cohen, I.1
Rosen, D.J.D.2
Shapira, J.3
Cordoba, M.4
Gilboa, S.5
Altaras, M.M.6
Yigael, D.7
-
17
-
-
0027564943
-
Clinical study of 381 postmenopasual bleeding patients
-
Lin H H, Wu M Y, Shyu M K, Chen D, Tsai J L, Hsieh C Y. Clinical study of 381 postmenopasual bleeding patients. J Formosan Med Assoc. 92:1993;41-44.
-
(1993)
J Formosan Med Assoc
, vol.92
, pp. 41-44
-
-
Lin, H.H.1
Wu, M.Y.2
Shyu, M.K.3
Chen, D.4
Tsai, J.L.5
Hsieh, C.Y.6
-
18
-
-
0020034128
-
Treatment of hyperplasia and carcinoma in situ of endometrium
-
Kistner R W. Treatment of hyperplasia and carcinoma in situ of endometrium. Clin Obstet Gynecol. 5:1982;63-72.
-
(1982)
Clin Obstet Gynecol
, vol.5
, pp. 63-72
-
-
Kistner, R.W.1
-
19
-
-
0027223453
-
Ultrasonographic evaluation of the endometrium and correlation with endometrial sampling in postmenopausal patients with tamoxifen
-
Cohen I, Rosen D JD, Tepper R, Cordoba M, Shapira Y, Altaras M M, Yigael D, Beyth Y. Ultrasonographic evaluation of the endometrium and correlation with endometrial sampling in postmenopausal patients with tamoxifen. J Ultra Med. 5:1993;275-280.
-
(1993)
J Ultra Med
, vol.5
, pp. 275-280
-
-
Cohen, I.1
Rosen, D.J.D.2
Tepper, R.3
Cordoba, M.4
Shapira, Y.5
Altaras, M.M.6
Yigael, D.7
Beyth, Y.8
-
20
-
-
0024342503
-
Correlation of ultrasound findings and endometrial histopathology in postmenopausal women
-
Nasari M N, Coast G J. Correlation of ultrasound findings and endometrial histopathology in postmenopausal women. Br J Obstet Gynaecol. 96:1989;133-138.
-
(1989)
Br J Obstet Gynaecol
, vol.96
, pp. 133-138
-
-
Nasari, M.N.1
Coast, G.J.2
-
21
-
-
0025091326
-
Endometrium assessed by vaginal ultrasonography before endometrial sampling in patients with postmenopausal bleeding
-
Goldstein S R, Nachtigall M, Snyder J R, Nachtigall L. Endometrium assessed by vaginal ultrasonography before endometrial sampling in patients with postmenopausal bleeding. Am J Obstet Gynecol. 163:1990;119-123.
-
(1990)
Am J Obstet Gynecol
, vol.163
, pp. 119-123
-
-
Goldstein, S.R.1
Nachtigall, M.2
Snyder, J.R.3
Nachtigall, L.4
-
22
-
-
0028842162
-
Effects of long-term administration of tamoxifen on vaginal epithelium and complications of endometrial lesions in breast cancer patients
-
Yokosuka K, Teshima H, Katase K, Fujimoto I, Yamauchi K, Hasumi K, Tatsuki Y. Effects of long-term administration of tamoxifen on vaginal epithelium and complications of endometrial lesions in breast cancer patients. Acta Obstet Gynaecol Jpn. 47:1995;125-132.
-
(1995)
Acta Obstet Gynaecol Jpn
, vol.47
, pp. 125-132
-
-
Yokosuka, K.1
Teshima, H.2
Katase, K.3
Fujimoto, I.4
Yamauchi, K.5
Hasumi, K.6
Tatsuki, Y.7
|